1.50
前日終値:
$1.51
開ける:
$1.52
24時間の取引高:
458.14K
Relative Volume:
0.34
時価総額:
$80.20M
収益:
-
当期純損益:
$-59.69M
株価収益率:
-1.0791
EPS:
-1.39
ネットキャッシュフロー:
$-46.54M
1週間 パフォーマンス:
+4.90%
1か月 パフォーマンス:
-33.33%
6か月 パフォーマンス:
-30.23%
1年 パフォーマンス:
+6.38%
Milestone Pharmaceuticals Inc Stock (MIST) Company Profile
名前
Milestone Pharmaceuticals Inc
セクター
電話
(514) 336-0444
住所
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, QC
MIST を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MIST
Milestone Pharmaceuticals Inc
|
1.50 | 130.00M | 0 | -59.69M | -46.54M | -1.39 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Milestone Pharmaceuticals Inc Stock (MIST) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-05 | 再開されました | H.C. Wainwright | Buy |
2024-08-22 | 開始されました | Rodman & Renshaw | Buy |
2023-06-20 | ダウングレード | Jefferies | Buy → Hold |
2022-04-22 | アップグレード | Piper Sandler | Neutral → Overweight |
2021-03-05 | 開始されました | H.C. Wainwright | Buy |
2020-07-29 | アップグレード | Oppenheimer | Perform → Outperform |
2020-07-24 | アップグレード | Jefferies | Hold → Buy |
2020-03-25 | ダウングレード | Jefferies | Buy → Hold |
2020-03-24 | ダウングレード | Oppenheimer | Outperform → Perform |
2020-03-24 | ダウングレード | Piper Sandler | Overweight → Neutral |
2019-06-04 | 開始されました | Oppenheimer | Outperform |
2019-06-03 | 開始されました | Cowen | Outperform |
2019-06-03 | 開始されました | Jefferies | Buy |
2019-06-03 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Milestone Pharmaceuticals Inc (MIST) 最新ニュース
Milestone Pharmaceuticals Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
What drives Milestone Pharmaceuticals Inc. stock priceAchieve rapid portfolio growth with smart picks - Jammu Links News
What analysts say about Milestone Pharmaceuticals Inc. stockCapitalize on market momentum for maximum profit - Jammu Links News
Should I hold or sell Milestone Pharmaceuticals Inc. stock in 2025Consistently outstanding ROI - Jammu Links News
How many analysts rate Milestone Pharmaceuticals Inc. as a “Buy”Exponential return rates - Jammu Links News
Is Milestone Pharmaceuticals Inc. stock overvalued or undervaluedFree Daily Trading Room Entry - Jammu Links News
How volatile is Milestone Pharmaceuticals Inc. stock compared to the marketInvest confidently with actionable market data - Jammu Links News
What are the latest earnings results for Milestone Pharmaceuticals Inc.Capitalize on emerging trends for profits - Jammu Links News
What are analysts’ price targets for Milestone Pharmaceuticals Inc. in the next 12 monthsTrack high-yield stocks before they peak - Jammu Links News
What catalysts could drive Milestone Pharmaceuticals Inc. stock higher in 2025Invest confidently with advanced analysis tools - Jammu Links News
How does Milestone Pharmaceuticals Inc. compare to its industry peersMaximize your gains with professional insights - Jammu Links News
Arrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough Deal - MSN
Why Milestone Pharmaceuticals Inc. stock attracts strong analyst attentionConsistent Gain Investment Strategies Emerge - metal.it
Trading Bots Trigger Alerts on Milestone Pharmaceuticals Inc. ActivityReal Time Trade Opportunity Alerts Monitor Market Surges - metal.it
Can Milestone Pharmaceuticals Inc. hit a new high this monthSwing Setup With Technical Confirmation Explained - metal.it
RSI Suggests Rebound May Be Near in Milestone Pharmaceuticals Inc.Accurate Buy Point for Momentum Stocks Detected - metal.it
Published on: 2025-07-29 04:32:28 - beatles.ru
Arrowhead Pharmaceuticals Earns $100 Million Milestone from Sarepta Therapeutics - Business Wire
Is it the right time to buy Milestone Pharmaceuticals Inc. stockFree Capital Allocation Plans - Jammu Links News
What makes Milestone Pharmaceuticals Inc. stock price move sharplyMaximize profits with strategic stock selection - Jammu Links News
How Efficient Is Milestone Pharmaceuticals Inc. at Controlling Operating CostsFree Stock Selection - metal.it
Is Milestone Pharmaceuticals Inc. stock a good hedge against inflationFree Access to Group - metal.it
Atrial Fibrillation (AF) Pipeline Market Research Report 2025 | Insights on 10+ Companies and 12+ Drugs in the Pipeline Landscape - GlobeNewswire Inc.
Is Milestone Pharmaceuticals Inc. a good long term investmentExtraordinary earning power - printweek.in
Milestone Pharmaceuticals Inc. Stock Analysis and ForecastFree Stock Movement Tracking - Autocar Professional
Is Milestone Pharmaceuticals Inc. stock a growth or value playFree Advanced Stock Screener Access - jammulinksnews.com
Milestone Pharmaceuticals Inc (MIST) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):